DBS vs focused ultrasound shows a hand interacting with medical equipment in a hospital.

DBS vs Focused Ultrasound for Essential Tremor: How to Choose

Reviewed by Carol Chiang
Reviewed by Carol Chiang

Occupational Therapist - Parkinson's Advocate

Share

Find Out More About Steadi-3 Plus

Get Steadi-3 Plus

DBS vs focused ultrasound for essential tremor is a surgical decision facing patients whose tremor has not responded adequately to medication. Both procedures target the VIM nucleus of the thalamus, and both are reserved for medication-refractory Essential Tremor. They differ fundamentally in mechanism, reversibility, candidacy requirements, and recovery. This article walks through how the two procedures compare and what determines which option is appropriate for a given patient.

Two Surgical Paths for Medication-Refractory Essential Tremor

Both deep-brain stimulation and focused ultrasound thalamotomy are reserved for patients where propranolol, primidone, and second-line medications have failed to provide adequate tremor control. DBS received FDA approval for Essential Tremor in 1997; MRgFUS received FDA clearance in 2016. The structural difference between them is fundamental: DBS modulates tremor signals through an implanted electrode without destroying tissue, while focused ultrasound creates a permanent thermal lesion in the VIM nucleus without any incision. Decades of outcome data exist for DBS; robust five-year data are now established for focused ultrasound.

How Deep Brain Stimulation Works for Essential Tremor

Deep brain stimulation for a tremor shows a patient undergoing EEG brainwave scanning with an electrode cap.

Deep brain stimulation involves implanting a thin electrode into the VIM nucleus of the thalamus, connected to a neurostimulator placed near the collarbone. Electrical current modulates the abnormal neural signals that drive tremor. The procedure has been performed in over 80,000 patients globally, with clinical studies reporting up to 90% improvement in hand tremor. The key clinical advantage is adjustability: device settings can be changed after implantation as the disease progresses. Bilateral treatment is possible. Multiple programming sessions follow surgery before optimal tremor control is achieved. 

How Focused Ultrasound Thalamotomy Works for Essential Tremor

Focused ultrasound thalamotomy uses converging ultrasound waves guided by real-time MRI to heat and permanently destroy targeted tissue in the VIM nucleus. No incision and no implants are involved. The patient is awake throughout, providing real-time feedback that guides targeting accuracy. It is performed as an outpatient procedure with same-day discharge. Published clinical data report 50-75% improvement in tremor for Essential Tremor. The critical distinction from DBS is permanence: the lesion cannot be adjusted, reversed, or re-treated at the same location. 

DBS vs Focused Ultrasound for Essential Tremor: Key Differences

Six dimensions determine which procedure is most suitable for a given patient. Reversibility: DBS is adjustable and can be turned off; FUS creates a permanent lesion. Bilateral treatment: DBS addresses both sides; staged bilateral FUS requires a nine-month minimum wait. Recovery: DBS requires hospitalization and a weeks-long programming phase; FUS is same-day outpatient. Hardware: DBS carries risks of infection and battery replacement; FUS involves no implants. Skull density: FUS requires a ratio of at least 0.45. Long-term adaptability: DBS settings are updated as the disease progresses; FUS remains fixed. 

The Skull Density Problem: Why Some Patients Cannot Have Focused Ultrasound

Approximately 15 to 20% of patients screened for focused ultrasound Essential Tremor treatment are excluded due to inadequate skull density ratio. FUS requires ultrasound waves to pass through the skull uniformly to reach the VIM nucleus with precision. High bone porosity scatters the waves, reducing targeting accuracy and increasing the risk of heating non-targeted tissue. An SDR of at least 0.45 is required and assessed via CT scan during pre-surgical screening. DBS has no equivalent anatomical barrier and is unaffected by skull density. 

Who Is a Better Candidate for DBS?

DBS is the more appropriate surgical path for patients with bilateral hand tremor affecting both sides meaningfully. Younger patients for whom long-term treatment flexibility matters are strong candidates, as settings can be adjusted as Essential Tremor progresses. Patients excluded from focused ultrasound due to skull anatomy, those with Parkinson's Disease needing broader motor symptom control, and patients prepared for device maintenance over many years are also well-suited. DBS requires a willingness to undergo general anesthesia, accept implanted hardware, and commit to ongoing programming follow-up. 

Who Is a Better Candidate for Focused Ultrasound Thalamotomy?

Focused ultrasound is better suited for patients with predominantly unilateral tremor affecting the dominant hand, older patients who prefer to avoid implant surgery, and those with comorbidities that increase surgical risk under general anesthesia. Adequate skull density ratio of at least 0.45 is a prerequisite. Anticoagulated patients face elevated DBS surgical risk and may be better served by FUS. Johns Hopkins data support over 80% improvement rates in appropriately selected patients. Patients must understand and accept that the thermal lesion is permanent and non-adjustable. 

Long-Term Outcomes: What the Research Shows

Long-term outcome data now exist for both procedures. DBS efficacy data spans over 20 years and confirms sustained benefit with ongoing programming. A 2026 meta-analysis by Sabet et al. found bilateral DBS statistically superior to unilateral MRgFUS in total Clinical Rating Scale for Tremor scores. Focused ultrasound data show 73% tremor improvement sustained at five-year follow-up. However, a subset of FUS patients experience tremor recurrence as the lesion evolves. Unlike DBS, the FUS lesion cannot be adjusted when tremor returns, which carries the most clinical weight for younger patients. 

Risks and Side Effects to Discuss with Your Neurosurgeon

Both procedures carry documented adverse event profiles. DBS hardware risks include infection in approximately 1 to 3% of cases, lead displacement, intracranial hemorrhage, and battery replacement surgery every three to five years. Programming-related side effects include changes in speech and balance. For focused ultrasound, adverse events are primarily transient paresthesia and gait imbalance, most resolving within months. A systematic review by Giordano et al. found persistent complications to be more common with MRgFUS than with DBS. A small risk of permanent neurological effects from the thermal lesion exists. Neither procedure guarantees complete tremor elimination. 

Questions to Ask Your Neurosurgeon Before Choosing

Before any procedure, patients should ask: Am I a candidate for both DBS and focused ultrasound, or does my anatomy restrict me to one? What is my skull density ratio? Do I have bilateral tremor requiring treatment on both sides? How will either procedure accommodate tremor progression over time? What is the long-term follow-up and device maintenance plan for DBS? What are the institutional outcome rates at this surgical center? Is this procedure covered by my insurance or Medicare plan? Consulting a movement-disorder neurologist, rather than performing the surgery, is advisable. 

When Surgery Is Not the Right Fit: Daily Tremor Management with the Steadi-3

Steadi-3 tremor glove worn as a non-surgical Essential Tremor treatment alternative.

 

Many Essential Tremor patients are not surgical candidates. Some have tremors not severe enough to meet surgical thresholds. Others have skull anatomy excluding focused ultrasound or comorbidities, making DBS inadvisable. For this population, non-surgical daily tremor management is a clinically meaningful option. The Steadi-3 is a battery-free, FDA-registered Class I medical device using patented passive magnetic stabilization to reduce hand tremor during eating, writing, and daily tasks. No electrical components, no prescription, and no surgical risk are involved. Clinical validation showed that 84% of users reported a significant reduction in tremor. 

Conclusion:

Both deep brain stimulation and focused ultrasound are clinically validated for medication-refractory Essential Tremor, with decades of evidence supporting DBS and robust five-year data now available for MRgFUS. The choice depends on whether bilateral treatment is needed, whether skull anatomy allows focused ultrasound, and how important long-term adjustability is, given the disease trajectory. DBS is suitable for patients needing bilateral control and future flexibility. FUS is suitable for patients with unilateral tremor, adequate skull density, and a preference for no implanted hardware. Both decisions require evaluation by a qualified neurosurgeon and movement disorder neurologist. 

FAQs

Neither is universally better. Both achieve significant tremor reduction in appropriately selected patients. DBS offers bilateral treatment capability and long-term adjustability; FUS offers no implanted hardware and same-day outpatient recovery. A 2026 meta-analysis found bilateral DBS to be statistically superior to unilateral MRgFUS in total tremor score, but this comparison reflects differences in patient profiles as much as in procedural performance. The right choice depends on tremor bilaterality, skull anatomy, surgical risk tolerance, and whether a reversible versus permanent intervention better suits the individual's situation. A movement disorder neurologist should evaluate both options with the patient.

Yes. DBS can be performed as a rescue treatment when focused ultrasound thalamotomy produces insufficient tremor control or when tremor recurs over time. Published case reports confirm the feasibility of DBS following failed focused ultrasound treatment for Essential Tremor. The thermal lesion created by FUS does not prevent subsequent DBS implantation in most patients. This is a clinically important consideration, particularly for younger patients for whom tremor may progress over decades. Patients should ask their surgical team about rescue options before choosing FUS, as the procedure's permanence and lack of adjustability make the initial decision consequential.

Skull density ratio measures how effectively ultrasound waves can pass through the skull to reach the thalamic target. It is calculated from a CT scan performed during pre-surgical screening. Patients with an SDR below approximately 0.45 are generally not candidates for focused ultrasound thalamotomy because a low SDR leads to wave scattering, reducing targeting precision and increasing the risk of heating tissue outside the intended area. SDR is one of the primary reasons otherwise eligible patients are excluded from MRgFUS Essential Tremor treatment. DBS does not have an equivalent anatomical prerequisite, making it available to a broader range of patients anatomically.

DBS is considered reversible in the clinically meaningful sense that the device can be turned off and, if necessary, surgically removed. The electrode modulates neural signals with electrical current rather than destroying tissue, which is the fundamental distinction from focused ultrasound thalamotomy. In practice, the stimulation is typically adjusted rather than reversed. Hardware removal carries its own surgical risks and is uncommon. Adjustability over time remains DBS's primary clinical advantage: as Essential Tremor or underlying disease progresses, device settings can be reprogrammed without additional brain procedures. This reversibility stands in direct contrast to the permanent lesion created by focused ultrasound.

Clinical studies show that focused ultrasound thalamotomy produces significant, sustained tremor reduction for up to 5 years in most patients. A multicenter controlled study reported 73% improvement in tremor at five-year follow-up. However, a subset of patients experience tremor recurrence as the thalamic lesion evolves or as the underlying neurological condition progresses. Unlike DBS, the lesion cannot be adjusted or re-treated if tremor returns, though DBS rescue treatment is an option in some cases. Patients should discuss realistic long-term expectations with their neurologist before choosing focused ultrasound treatment for Essential Tremor, particularly if the underlying condition is progressive.

Patients who are not surgical candidates, whose tremor is mild to moderate, or who prefer non-surgical management have meaningful options. Medications, including propranolol and primidone, remain first-line and provide adequate control for approximately 50% of patients. For those who do not respond adequately to medication or are managing functional tremor alongside other treatments, wearable assistive devices are a clinically grounded option. The Steadi-3 is an FDA-registered Class I medical device that uses passive magnetic stabilization to reduce hand tremor during daily tasks. Occupational therapy can further support daily activity management. A healthcare provider should guide the combination of strategies appropriate for the individual's specific symptom profile and stage.

Continue reading

Deep brain stimulation recovery, where a senior woman is seated in a wheelchair inside a hospital.

DBS Surgery Recovery Time: What to Expect After Deep Brain Stimulation